Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Inventory (2016 - 2025)

Cumberland Pharmaceuticals' Change in Inventory history spans 16 years, with the latest figure at $205989.0 for Q4 2025.

  • For Q4 2025, Change in Inventory rose 115.42% year-over-year to $205989.0; the TTM value through Dec 2025 reached -$2.2 million, up 6.88%, while the annual FY2025 figure was -$2.2 million, 6.88% up from the prior year.
  • Change in Inventory for Q4 2025 was $205989.0 at Cumberland Pharmaceuticals, up from -$630409.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.6 million in Q3 2022 and bottomed at -$2.3 million in Q1 2022.
  • The 5-year median for Change in Inventory is -$630409.0 (2025), against an average of -$591469.6.
  • The largest annual shift saw Change in Inventory soared 756.09% in 2022 before it plummeted 468.77% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$2.3 million in 2021, then soared by 118.92% to $427803.0 in 2022, then decreased by 24.37% to $323557.0 in 2023, then tumbled by 512.94% to -$1.3 million in 2024, then soared by 115.42% to $205989.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Change in Inventory are $205989.0 (Q4 2025), -$630409.0 (Q3 2025), and -$850797.0 (Q2 2025).